Sofosbuvir (CAS 1190307-88-0) Market Report

Global and China Sofosbuvir (CAS 1190307-88-0) Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 06, 2022
  • PAGES：227
  • REPORT CODE：GMM1439645
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Sofosbuvir (CAS 1190307-88-0) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Teva Pharmaceutical Industries Ltd

    • NIFTY LABS PVT LTD

    • DEAFARMA

    • SMS Pharmaceuticals Limited

    • Beijing Kawin Technology Share-holding Co

    • Manus Aktteva Biopharma LLP

    • Hangzhou Longshine Bio-Tech Co

    • Tecoland

    • Sinobright Pharmaceutical Company Limited

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Above 98% Purity

    • Below 98% Purity

    Application:

    • 400mg Tablets

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Sofosbuvir (CAS 1190307-88-0) Industry Overview

      • 1.1.1 Sofosbuvir (CAS 1190307-88-0) Market Scope and Market Segments

      • 1.1.2 Sofosbuvir (CAS 1190307-88-0) Industry Characteristics

      • 1.1.3 Global and China Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Sofosbuvir (CAS 1190307-88-0) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Above 98% Purity

      • 1.2.2 Below 98% Purity

    • 1.3 Global Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 400mg Tablets

      • 1.3.2 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Sofosbuvir (CAS 1190307-88-0) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Sofosbuvir (CAS 1190307-88-0) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Sofosbuvir (CAS 1190307-88-0) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Sofosbuvir (CAS 1190307-88-0) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Sofosbuvir (CAS 1190307-88-0) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Sofosbuvir (CAS 1190307-88-0) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Sofosbuvir (CAS 1190307-88-0) Industry PEST Analysis

    • 2.3 Sofosbuvir (CAS 1190307-88-0) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Sofosbuvir (CAS 1190307-88-0) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Sofosbuvir (CAS 1190307-88-0) Industry

    Chapter 3 Global and China Sofosbuvir (CAS 1190307-88-0) Market, by Manufacturer

    • 3.1 Global and China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Sofosbuvir (CAS 1190307-88-0) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Sofosbuvir (CAS 1190307-88-0) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Sofosbuvir (CAS 1190307-88-0) Market Top 3 Players

    Chapter 4 Global and China Sofosbuvir (CAS 1190307-88-0) Market, by Type (2017-2028)

    • 4.1 Sofosbuvir (CAS 1190307-88-0) Market Trend, by Type

    • 4.2 Global Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Sofosbuvir (CAS 1190307-88-0) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Sofosbuvir (CAS 1190307-88-0) Price Trend, by Type (2017-2028)

    • 4.3 China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Sofosbuvir (CAS 1190307-88-0) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Sofosbuvir (CAS 1190307-88-0) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Sofosbuvir (CAS 1190307-88-0) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Sofosbuvir (CAS 1190307-88-0) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Sofosbuvir (CAS 1190307-88-0) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Sofosbuvir (CAS 1190307-88-0) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Sofosbuvir (CAS 1190307-88-0) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 7.1 North America Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 7.2 North America Sofosbuvir (CAS 1190307-88-0) Market, by Application

    • 7.3 North America Sofosbuvir (CAS 1190307-88-0) Market Analysis and Forecast, by Country

      • 7.3.1 United States Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 8.1 Europe Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 8.2 Europe Sofosbuvir (CAS 1190307-88-0) Market, by Application

    • 8.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 9.1 APAC Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 9.2 APAC Sofosbuvir (CAS 1190307-88-0) Market, by Application

    • 9.3 APAC Sofosbuvir (CAS 1190307-88-0) Market Analysis and Forecast, by Country

      • 9.3.1 China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Analysis

    • 10.1 Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market, by Type

    • 10.2 Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market, by Application

    • 10.3 Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Sofosbuvir (CAS 1190307-88-0) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Sofosbuvir (CAS 1190307-88-0) Company Profiles

      • 11.1 Teva Pharmaceutical Industries Ltd

        • 11.1.1 Teva Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 NIFTY LABS PVT LTD

        • 11.2.1 NIFTY LABS PVT LTD Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.2.3 NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 DEAFARMA

        • 11.3.1 DEAFARMA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.3.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 SMS Pharmaceuticals Limited

        • 11.4.1 SMS Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.4.3 SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Beijing Kawin Technology Share-holding Co

        • 11.5.1 Beijing Kawin Technology Share-holding Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.5.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Manus Aktteva Biopharma LLP

        • 11.6.1 Manus Aktteva Biopharma LLP Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.6.3 Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Hangzhou Longshine Bio-Tech Co

        • 11.7.1 Hangzhou Longshine Bio-Tech Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.7.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Tecoland

        • 11.8.1 Tecoland Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.8.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Sinobright Pharmaceutical Company Limited

        • 11.9.1 Sinobright Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Product Profiles, Application and Specification

        • 11.9.3 Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Sofosbuvir (CAS 1190307-88-0) Industry Investment Prospect and Risk Assessment

    • 12.1 Sofosbuvir (CAS 1190307-88-0) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Sofosbuvir (CAS 1190307-88-0) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Production Value and Growth Rate (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Production Value and Growth Rate (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate of Above 98% Purity (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate of Below 98% Purity (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate of 400mg Tablets (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Sofosbuvir (CAS 1190307-88-0) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Sofosbuvir (CAS 1190307-88-0) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Sofosbuvir (CAS 1190307-88-0) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Sofosbuvir (CAS 1190307-88-0) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Sofosbuvir (CAS 1190307-88-0) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Sofosbuvir (CAS 1190307-88-0) Market Share, by Manufacturer in 2021

    • Figure Global and China Sofosbuvir (CAS 1190307-88-0) Market Share, by Manufacturer in 2022

    • Table Global Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Type (2017-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Sales Value, by Type (2017-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Sales Value Share, by Type (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Price Trend, by Type (2017-2028)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Type (2017-2028)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Value, by Type (2017-2028)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Value Share, by Type (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Price Trend, by Type (2017-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Application (2017-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Sales Value, by Application (2017-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Sales Value Share, by Application (2017-2028)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Value Share, by Application (2017-2028)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Application (2017-2028)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Value, by Application (2017-2028)

    • Table China Sofosbuvir (CAS 1190307-88-0) Sales Value Share, by Application (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Value Share, by Application (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Production, Import, Consumption and Export (2017-2022)

    • Table North America Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Type (2017-2028)

    • Table North America Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Figure North America Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Table North America Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Application (2017-2028)

    • Table North America Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure North America Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure United States Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Table Europe Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Type (2017-2028)

    • Table Europe Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Table Europe Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Application (2017-2028)

    • Table Europe Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure UK Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure France Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure France Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Table APAC Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Type (2017-2028)

    • Table APAC Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Table APAC Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Application (2017-2028)

    • Table APAC Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure India Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure India Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Sofosbuvir (CAS 1190307-88-0) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Sofosbuvir (CAS 1190307-88-0) Sales Value and Growth Rate (2017-2028)

    • Table Teva Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries Ltd Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NIFTY LABS PVT LTD Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NIFTY LABS PVT LTD Product Profiles, Application and Specification

    • Table NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table DEAFARMA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table DEAFARMA Product Profiles, Application and Specification

    • Table DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table SMS Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table SMS Pharmaceuticals Limited Product Profiles, Application and Specification

    • Table SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Beijing Kawin Technology Share-holding Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Beijing Kawin Technology Share-holding Co Product Profiles, Application and Specification

    • Table Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Manus Aktteva Biopharma LLP Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Manus Aktteva Biopharma LLP Product Profiles, Application and Specification

    • Table Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hangzhou Longshine Bio-Tech Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hangzhou Longshine Bio-Tech Co Product Profiles, Application and Specification

    • Table Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tecoland Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tecoland Product Profiles, Application and Specification

    • Table Tecoland Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sinobright Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sinobright Pharmaceutical Company Limited Product Profiles, Application and Specification

    • Table Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US